Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G A BASKHAEVA"'
Autor:
E N PAROVICHNIKOVA, I A LOUKIANOVA, V V TROITSKAYA, M Y DROKOV, T I LOBAOVA, L A KUZMINA, A N SOKOLOV, A V KOKHNO, Z T FIDAROVA, G A BASKHAEVA, O A GAVRILINA, V A VASILYEVA, T N OBUKHOVA, S A KUZNETSOVA, A B SUDARIKOV, V N DVIRNIK, I V GALTSEVA, J O DAVIDIVA, S M KULIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Externí odkaz:
https://doaj.org/article/86c14a4b80d349a59c1c8acc0003408d
Autor:
K I ZARUBINA, E N PAROVICHNIKOVA, G A BASKHAEVA, A E KRASILNIKOVA, O A GAVRILINA, B V BIDERMAN, A B SUDARIKOV, S N BONDARENKO, Y O DAVYDOVA, I V GALTSEVA, A N SOKOLOV, V V TROITSKAYA, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 110-117 (2018)
B-cell acute lymphoblastic leukemia (B-ALL) is a diverse group of malignant blood disorders both with regard to the biological properties of the tumor and to therapeutic approaches. Immunophenotyping, molecular genetic techniques, whole-genome sequen
Externí odkaz:
https://doaj.org/article/c3265da0ddc142569d2dbeb8caaa9524
Autor:
E N Parovichnikova, V V Troitskaya, A N Sokolov, S N Bondarenko, O A Gavrilina, G A Baskhaeva, B V Biderman, I A Lukyanova, L A Kuz'mina, G A Klyasova, S K Kravchenko, E O Gribanova, E E Zvonkov, Z Kh Akhmerzaeva, O Yu Baranova, T S Kaporskaya, T V Ryltsova, E N Zotina, E E Zinina, O S Samoilova, K D Kaplanov, L V Gavrilova, T S Konstantinova, V A Lapin, A S Pristupa, A S Eluferyeva, T N Obukhova, I S Piskunova, I V Gal'tseva, V N Dvirnyk, M A Rusinov, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 10-17 (2017)
Aim. To analyze the efficiency and reproducibility of the ALL-2009 protocol within the Russian prospective multicenter study based on different principles of cytostatic effects (non-intensive, but continuous cytotoxic treatment and a small number of
Externí odkaz:
https://doaj.org/article/70eebaa576c444a0a015d4c4e514ab53
Autor:
E N Parovichnikova, A N Sokolov, V V Troitskaya, G A Klyasova, M A Rusinov, Z Kh Akhmerzaeva, L A Kuzmina, S N Bondarenko, O Yu Baranova, T S Kaporskaya, E N Zotina, E E Zinina, O S Samoilova, L V Gavrilova, K D Kaplanov, T S Konstantinova, V A Lapin, S K Kravchenko, E O Gribanova, E E Zvonkov, O A Gavrilina, G A Baskhaeva, G M Galstyan, T N Obukhova, I V Galtseva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
Aim. To analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute
Externí odkaz:
https://doaj.org/article/b71326aeda7841e4b4714c86f887ce4f
Autor:
Irina V. Galtseva, T N Obukhova, S A Kuznetsova, Larisa A. Kuzmina, A N Sokolov, V A Vasilyeva, J O Davidiva, Elena N. Parovichnikova, Valery G. Savchenko, Olga A. Gavrilina, Vera V. Troitskaya, I A Loukianova, Sergei M. Kulikov, Zalina T. Fidarova, Andrey Sudarikov, Mikhail Yu. Drokov, V.N. Dvirnik, T I Lobaova, A V Kokhno, G A Baskhaeva
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Autor:
A E Krasilnikova, Vera V. Troitskaya, G A Baskhaeva, Andrey Sudarikov, Yuliya O. Davydova, Sergey N. Bondarenko, A N Sokolov, Valery G. Savchenko, B V Biderman, Olga A. Gavrilina, Elena N. Parovichnikova, Irina V. Galtseva, K. I. Zarubina
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 110-117 (2018)
B-cell acute lymphoblastic leukemia (B-ALL) is a diverse group of malignant blood disorders both with regard to the biological properties of the tumor and to therapeutic approaches. Immunophenotyping, molecular genetic techniques, whole-genome sequen
Autor:
Olga Samoilova, Olga A. Gavrilina, A N Sokolov, Sergei M. Kulikov, G M Galstyan, Z Kh Akhmerzaeva, T N Obukhova, Valery G. Savchenko, L V Gavrilova, Irina V. Galtseva, M A Rusinov, Elena O. Gribanova, E E Zinina, G A Baskhaeva, E E Zvonkov, E N Zotina, Elena N. Parovichnikova, G A Klyasova, Sergey N. Bondarenko, T S Kaporskaya, O Yu Baranova, V A Lapin, Vera V. Troitskaya, K D Kaplanov, T S Konstantinova, Larisa A. Kuzmina, Kravchenko Sk
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
to analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute lymp